BCRX
Price
$11.04
Change
+$0.06 (+0.55%)
Updated
Jun 6, 04:59 PM (EDT)
Capitalization
2.3B
55 days until earnings call
IGXT
Price
$0.17
Change
-$0.00 (-0.00%)
Updated
May 16 closing price
Capitalization
29.17M
67 days until earnings call
Interact to see
Advertisement

BCRX vs IGXT

Header iconBCRX vs IGXT Comparison
Open Charts BCRX vs IGXTBanner chart's image
BioCryst Pharmaceuticals
Price$11.04
Change+$0.06 (+0.55%)
Volume$67.25K
Capitalization2.3B
IntelGenx Technologies
Price$0.17
Change-$0.00 (-0.00%)
Volume$37.23K
Capitalization29.17M
BCRX vs IGXT Comparison Chart
Loading...
BCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BCRX vs. IGXT commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCRX is a Hold and IGXT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (BCRX: $10.97 vs. IGXT: $0.17)
Brand notoriety: BCRX: Notable vs. IGXT: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCRX: 71% vs. IGXT: 100%
Market capitalization -- BCRX: $2.3B vs. IGXT: $29.17M
BCRX [@Biotechnology] is valued at $2.3B. IGXT’s [@Biotechnology] market capitalization is $29.17M. The market cap for tickers in the [@Biotechnology] industry ranges from $324.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCRX’s FA Score shows that 1 FA rating(s) are green whileIGXT’s FA Score has 1 green FA rating(s).

  • BCRX’s FA Score: 1 green, 4 red.
  • IGXT’s FA Score: 1 green, 4 red.
According to our system of comparison, BCRX is a better buy in the long-term than IGXT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCRX’s TA Score shows that 3 TA indicator(s) are bullish.

  • BCRX’s TA Score: 3 bullish, 5 bearish.

Price Growth

BCRX (@Biotechnology) experienced а +0.83% price change this week, while IGXT (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +11.92%. For the same industry, the average monthly price growth was +17.56%, and the average quarterly price growth was +3.51%.

Reported Earning Dates

BCRX is expected to report earnings on Jul 31, 2025.

IGXT is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+11.92% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BCRX($2.3B) has a higher market cap than IGXT($29.2M). BCRX YTD gains are higher at: 45.878 vs. IGXT (0.000). BCRX has higher annual earnings (EBITDA): 47.6M vs. IGXT (-8.16M). BCRX has more cash in the bank: 295M vs. IGXT (772K). IGXT has less debt than BCRX: IGXT (16.5M) vs BCRX (795M). BCRX has higher revenues than IGXT: BCRX (503M) vs IGXT (1.05M).
BCRXIGXTBCRX / IGXT
Capitalization2.3B29.2M7,860%
EBITDA47.6M-8.16M-584%
Gain YTD45.8780.000-
P/E RatioN/AN/A-
Revenue503M1.05M47,859%
Total Cash295M772K38,212%
Total Debt795M16.5M4,818%
FUNDAMENTALS RATINGS
BCRX vs IGXT: Fundamental Ratings
BCRX
IGXT
OUTLOOK RATING
1..100
5547
VALUATION
overvalued / fair valued / undervalued
1..100
33
Fair valued
88
Overvalued
PROFIT vs RISK RATING
1..100
70100
SMR RATING
1..100
10099
PRICE GROWTH RATING
1..100
3970
P/E GROWTH RATING
1..100
1004
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BCRX's Valuation (33) in the Biotechnology industry is somewhat better than the same rating for IGXT (88) in the null industry. This means that BCRX’s stock grew somewhat faster than IGXT’s over the last 12 months.

BCRX's Profit vs Risk Rating (70) in the Biotechnology industry is in the same range as IGXT (100) in the null industry. This means that BCRX’s stock grew similarly to IGXT’s over the last 12 months.

IGXT's SMR Rating (99) in the null industry is in the same range as BCRX (100) in the Biotechnology industry. This means that IGXT’s stock grew similarly to BCRX’s over the last 12 months.

BCRX's Price Growth Rating (39) in the Biotechnology industry is in the same range as IGXT (70) in the null industry. This means that BCRX’s stock grew similarly to IGXT’s over the last 12 months.

IGXT's P/E Growth Rating (4) in the null industry is significantly better than the same rating for BCRX (100) in the Biotechnology industry. This means that IGXT’s stock grew significantly faster than BCRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BCRX
RSI
ODDS (%)
Bearish Trend 2 days ago
77%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
84%
Momentum
ODDS (%)
Bullish Trend 2 days ago
89%
MACD
ODDS (%)
Bearish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 11 days ago
79%
Declines
ODDS (%)
Bearish Trend 2 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
BCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPY593.05-2.88
-0.48%
SPDR® S&P 500® ETF
AAPL200.63-2.19
-1.08%
Apple
GME29.45-0.50
-1.67%
GameStop Corp
BTC.X101575.950000-3156.031200
-3.01%
Bitcoin cryptocurrency
TSLA284.70-47.35
-14.26%
Tesla

BCRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCRX has been loosely correlated with VCYT. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if BCRX jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCRX
1D Price
Change %
BCRX100%
-0.63%
VCYT - BCRX
46%
Loosely correlated
-1.17%
CRNX - BCRX
40%
Loosely correlated
+0.59%
COGT - BCRX
39%
Loosely correlated
+6.03%
VKTX - BCRX
39%
Loosely correlated
+0.15%
ROIV - BCRX
39%
Loosely correlated
-0.18%
More

IGXT and

Correlation & Price change

A.I.dvisor tells us that IGXT and ACET have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IGXT and ACET's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IGXT
1D Price
Change %
IGXT100%
N/A
ACET - IGXT
28%
Poorly correlated
-5.25%
DTIL - IGXT
27%
Poorly correlated
+1.27%
EDIT - IGXT
25%
Poorly correlated
-1.10%
CRSP - IGXT
24%
Poorly correlated
+1.37%
BCRX - IGXT
24%
Poorly correlated
-0.63%
More